Month: June 2024

MIAMI, June 26, 2024 (GLOBE NEWSWIRE) — AYR Cannabis Dispensary, a cannabis retail chain owned by AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), today announced the opening of AYR Cannabis Dispensary Hometown, the Company’s third retail location in Illinois and 92nd nationwide. Located in a suburb of Chicago at 4140 SW Hwy, Hometown, IL 60456, AYR Cannabis Dispensary Hometown began serving adult-use consumers on June 25. The dispensary features a welcoming environment for customers with a retail floor of approximately 4,200 square feet. “We’re proud to continue our growth in Illinois with the opening of AYR Cannabis Dispensary Hometown, our third location in the state and 92nd nationwide,” said David Goubert, President...

CHANDLER, Ariz., June 26, 2024 (GLOBE NEWSWIRE) — One of Microchip’s Guiding Values is “Professional Ethics and Social Responsibility Are Practiced,” which means that the company manages its business and treats its customers, employees, shareholders, investors, suppliers, channel partners, community and government in a manner that exemplifies honesty, ethics and integrity. To demonstrate its commitment to this value and to provide transparency to its employees, customers and all other stakeholders, Microchip Technology (Nasdaq: MCHP) has released its 2023 Sustainability Report which details its environmental and social impact programs. Microchip’s Environmental, Social and Governance (ESG) projects are aligned with its business objectives and are implemented to catalyze positive change throughout its value chain via strategic initiatives,...

LAS VEGAS, June 26, 2024 (GLOBE NEWSWIRE) — Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company is expecting to receive an expanded certified geological technical report during the 3rd quarter on its 100% owned registered concession at the Bonanza Gold Mine Project located in Acaponeta, Nayarit, Mexico. The Company will be broadening its ongoing exploration and development activities at Bonanza directed by the new guidances and recommendations contained in the upcoming second technical report. The outstanding indications revealed during the compilation process of the new report signify the potential for a substantial increase in development scope and production planning for the Bonanza property. The preliminary mineral resource estimates of gold and silver values contained in the initial...

Selected for oral presentation Conference will be held in Milan on September 21-23MADRID and CAMBRIDGE, Mass., June 26, 2024 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today announced that it will present final data from its Phase IIb PORTICO trial, which investigated the efficacy of vafidemstat in the treatment of Borderline Personality Disorder (BPD), as an oral presentation at the 37th European College of Neuropsychopharmacology (ECNP) annual conference, to be held on September 21-23, 2024 in Milan, Italy. Dr. Michael Ropacki, Oryzon’s Chief Medical Officer, Head of CNS Clinical Development, will be presenting the results at the ECNP New Medication Symposium on September...

– Phase 3 trial design for the LUGANO and LUCIA pivotal non-inferiority trials of DURAVYU in wet AMD based on positive EOP2 meeting with FDA; on track for trial initiation in 2H 2024 – – Positive twelve-month safety and efficacy data from Phase 2 DAVIO 2 clinical trial evaluating DURAVYU for the treatment of wet AMD reinforces potential as a sustained six-month maintenance therapy – – Phase 2 trial of DURAVYU in diabetic macular edema (DME) fully enrolled – – EyePoint to webcast its R&D Day event today at 8:00 a.m. ET – WATERTOWN, Mass., June 26, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious retinal diseases, today announced the Company will highlight clinical and regulatory developments...

Sole Source Contract will lead to further growth with the US GovernmentOPT WAM-VImage of OPT’s WAM-V USV.MONROE TOWNSHIP, N.J., June 26, 2024 (GLOBE NEWSWIRE) — Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative and cost-effective low-carbon marine power, data, and service solutions, today announced it has reached an agreement in principle on a sole source contract award for multiple WAM-Vs for delivery to a Department of the US Government. The final contract award will be a Firm-Fixed-Price purchase order on a noncompetitive basis. Revenue will be recognized ratably over the course of the contract with an expected near-term delivery date. Due to the sensitive nature of this relationship, terms have not been disclosed. This award builds on the recent commercial...

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION INTHE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, June 26, 2024 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) (TSX: CNT) is pleased to announce that it has filed its audited consolidated financial statements for the year ended March 31, 2024 and the related management discussion and analysis (“MD&A”) as well as the Annual Information Form. Copies of these documents are available under Century’s SEDAR+ profile at http://www.sedarplus.ca and will also be posted on Century’s website at www.centuryglobal.ca. As of March 31, 2024, the Company had net working capital* of $6.1 million, consisting of unrestricted free cash, bank deposits and marketable securities totaling $5.0 million, together with accounts receivables, inventories and other...

ESTERO, Fla., June 26, 2024 (GLOBE NEWSWIRE) — via IBN — GRN Holding Corporation, (OTC: GRNF) is proud to announce its strategic rebranding to Marijuana Inc. (www.marijuanainc.com) to signal a new era of growth and innovation in the global cannabis industry. This transformation is led by the renowned CEO, Donald Steinberg, whose illustrious career in the marijuana sector spans over five decades. Donald Steinberg: Recognized as the “Henry Ford of the Marijuana Industry.” Donald Steinberg, documented in multiple books for his pioneering efforts in the marijuana industry, has a storied history that sets him apart from all others in the field. In the 1980s, Steinberg was recognized by Centac, a U.S. government agency, as the largest importer of marijuana into the United States in the 1970s and the largest U.S. distributor....

Top line data to be reported in the second half of 2024 TEL AVIV, Israel, June 26, 2024 (GLOBE NEWSWIRE) — PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company“), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced a major milestone on the way to registration – the successful completion of patient enrollment in its Phase 3 clinical trial for PRF-110, a novel analgesic drug candidate designed for the treatment of post-operative pain. In total, 428 patients have been enrolled at eight clinical sites across the U.S. As the study pain score is being tracked for 72 hours, the end of enrollment is generally the end of the clinical part of the study. The Phase 3 trial, a randomized, double-blind, placebo-controlled study, is designed...